India's Marksans Pharma up 3% on manufacturing site acquisition

Marksans Pharma

19/04/2023 09:01

`    ** Shares of Marksans Pharma Ltd  MARK.NS  rise as much as
3.2% to 78.40 rupees
    ** Indian pharma firm completes acquisition of manufacturing
site from Tevapharm India in Goa
    ** Stock trading above its 50-, 100- and 200-day moving
averages
    ** About 1.4 mln shares change hands by 1:26 p.m. IST, 0.8x
the 30-day avg of 1.9 mln shares - Refinitiv Data
    ** Stock up 30.5% so far this year, as of last close

 (Reporting by Priya Sagar in Bengaluru)
 ((Priya.Sagar@thomsonreuters.com;))